Micro Emerging Active

Designação de Fast Track da FDA pela Climb Bio

New narrative with limited coverage — still forming.

Pontuação
0,5
Velocidade
▲ 1,0
Artigos
2
Fontes
1

Sentiment Timeline

Event Timeline

Abr 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
Abr 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

Artigos Relacionados

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · Abr 24, 2026
Mixed

Cronologia

Última atualizaçãoAbr 22, 2026